We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+26.23%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$2.44B
AUM Growth
+$792M
Cap. Flow
+$442M
Cap. Flow %
18.15%
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 9.57%
3 Financials 8.79%
4 Industrials 7.76%
5 Consumer Discretionary 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MD icon
1176
Pediatrix Medical
MD
$2.2B
$418K 0.02%
24,450
+58
+0.2% +$860
SDOW icon
1177
ProShares UltraPro Short Dow 30
SDOW
$183M
$418K 0.02%
1,087
-5,413
-83% -$2.69M
CNX icon
1178
CNX Resources
CNX
$5.2B
$417K 0.02%
48,153
+38,812
+416% +$390K
FATE icon
1179
Fate Therapeutics
FATE
$326M
$416K 0.02%
+12,119
New +$361K
OI icon
1180
O-I Glass
OI
$1.08B
$416K 0.02%
46,337
+40,868
+747% +$316K
WTS icon
1181
Watts Water Technologies
WTS
$13.1B
$416K 0.02%
+5,136
New +$414K
CCEP icon
1182
Coca-Cola Europacific Partners
CCEP
$47.9B
$415K 0.02%
10,967
+2,379
+28% +$93.3K
FIT
1183
DELISTED
Fitbit, Inc. Class A common stock
FIT
$415K 0.02%
+64,117
New +$419K
FOLD
1184
DELISTED
Amicus Therapeutics
FOLD
$414K 0.02%
+27,424
New +$334K
MDU icon
1185
MDU Resources
MDU
$4.32B
$413K 0.02%
48,979
+48,963
+306,019% +$407K
NULC icon
1186
Nuveen ESG Large-Cap ETF
NULC
$72.8M
$413K 0.02%
14,089
-1,387
-9% -$37.9K
RYN icon
1187
Rayonier
RYN
$6.55B
$413K 0.02%
+18,372
New +$400K
UHS icon
1188
Universal Health Services
UHS
$10.5B
$413K 0.02%
4,447
-269
-6% -$26.9K
HLI icon
1189
Houlihan Lokey
HLI
$9.02B
$412K 0.02%
+7,404
New +$431K
VICI icon
1190
VICI Properties
VICI
$29.4B
$412K 0.02%
20,429
+16,429
+411% +$301K
WAB icon
1191
Wabtec
WAB
$49.3B
$412K 0.02%
7,168
+1,627
+29% +$92.1K
MOG.A icon
1192
Moog Inc Class A
MOG.A
$12.8B
$411K 0.02%
+7,768
New +$399K
XCOM
1193
DELISTED
ProShares Ultra Communication Services Select Sector
XCOM
$411K 0.02%
+8,066
New +$374K
BAX icon
1194
Baxter International
BAX
$14.2B
$410K 0.02%
4,767
+2,368
+99% +$206K
SBB icon
1195
ProShares Short SmallCap600
SBB
$3.35M
$410K 0.02%
+6,667
New +$464K
WYNN icon
1196
Wynn Resorts
WYNN
$10.6B
$410K 0.02%
+5,504
New +$441K
MXIM
1197
DELISTED
Maxim Integrated Products
MXIM
$410K 0.02%
6,755
+2,242
+50% +$125K
DHC
1198
Diversified Healthcare Trust
DHC
$2.14B
$408K 0.02%
92,131
+91,377
+12,119% +$323K
LNTH icon
1199
Lantheus
LNTH
$6.59B
$407K 0.02%
+28,460
New +$376K
AMCR icon
1200
Amcor
AMCR
$22.1B
$406K 0.02%
7,959
+5,815
+271% +$271K

Similar funds

Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review

As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
  • Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
  • Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
  • Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.